BNP Paribas Financial Markets Sells 21,545 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
BNP Paribas Financial Markets cut its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 81.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,874 shares of the company’s stock after selling 21,545 shares during the period. BNP Paribas Financial Markets’ holdings in Y-mAbs Therapeutics were worth $38,000 as of its most […]
BNP Paribas Financial Markets cut its stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 81.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,874 shares of the company’s stock after selling 21,545 shares during the period. BNP Paribas Financial Markets’ holdings in Y-mAbs Therapeutics were worth $38,000 as of its most […]
